Please correct me if I am wrong - I am sure you all will
My understanding is that all the PD patients in this IIb trial improved to some degree, including those who received the placebo treatment.
Given that central nervous system neurons grow slowly, is it not possible that this improvement may continue in the people who received NTCell and dwindle in those who did not?
Especially as the NTCell recipient patients from the phase I trials were reported to be "continuing to improve" after 130 weeks (Living Insights July 2017)
Time may tell
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $5.157K | 645.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 5025110 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 311655 | 2 |
View Market Depth
| Last trade - 14.16pm 09/08/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |